No Data
CI Medical: Financial results presentation materials for the 3rd quarter of fiscal year 2012
CI Medical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)
Daiwa House, Idemitsu Kosan, Tokyo Electron Ltd. unsponsored adr, SoftBank Group (12th)
※Please note that the above calendar is subject to change depending on the company's circumstances. --------------------------------------- November 12 (Tuesday) ＜1431＞ Livework ＜146A＞ Colombia ＜148A＞ Hatchwork ＜1491＞ Chugai Mining ＜1605＞ INPEX ＜1663＞ K&O Energy ＜166A＞ Taski HD ＜1770＞ Fujita E
Nissan revised its operating profit downwards to 150 billion yen from 500 billion yen on March 25th.
Nissan <7201> announced a revision to its 2025 fiscal year financial estimates. The operating profit was revised downward from 500 billion yen to 150 billion yen. The assumed exchange rate was revised to 1 dollar = 149 yen (previously 1 dollar = 155 yen), and 1 euro = 164 yen (previously 1 euro = 167 yen). The global passengers carried is set at 3.4 million units, down from the previous estimate of 3.65 million units. It was also announced that they will sell some of the shareholding in Mitsubishi Motors <7211>. [Positive Assessment] <5801> Furukawa Electric midterm | <674
CI Medical: Notice regarding revisions to earnings forecasts
Stocks that moved the previous day, Part 2: Nitori HD, Metaplanet, Dental Medical, etc.
Stock name <code>26th closing price⇒Previous day comparison DMG Mori Seiki＜6141＞ 3315 -160 yen higher, believed to be greatly affected by the weak Euro. Yamaha Motor＜7272＞ 1217 -67.5, immediate supply and demand concerns due to the announcement of a major shareholder's sale. Nissan Motor Co＜7201＞ 422.9 -19, investment downgrade by JP Morgan Securities. Mazda Motor CRP＜7261＞ 1191.5, predominant selling pressure on automobile stocks due to the progress of the 41.5 yen rise. TOWA＜6315＞
No Data
No Data